首页> 外文期刊>Artificial cells, nanomedicine, and biotechnology. >Development of transethosomes formulation for dermal fisetin delivery: Box–Behnken design, optimization, in vitro skin penetration, vesicles–skin interaction and dermatokinetic studies
【24h】

Development of transethosomes formulation for dermal fisetin delivery: Box–Behnken design, optimization, in vitro skin penetration, vesicles–skin interaction and dermatokinetic studies

机译:透皮脂质体制剂用于真皮非瑟酮递送的开发:Box-Behnken设计,优化,体外皮肤渗透,囊泡-皮肤相互作用和皮肤动力学研究

获取原文
           

摘要

The present study was conducted for the optimization of transethosomes formulation for dermal fisetin delivery. The optimization of the formulation was carried out using “Box–Behnken design”. The independent variables were Lipoid S 100, ethanol and sodium cholate. The prepared formulations were characterized for vesicle size, entrapment efficiency and in vitro skin penetration study. The vesicles–skin interaction, confocal laser scanning microscopy and dermatokinetic studies were performed with optimized formulation. Results of the present study demonstrated that the optimized formulation presented vesicle size of 74.21?±?2.65?nm, zeta potential of ?11.0?mV, entrapment efficiency of 68.31?±?1.48% and flux of 4.13?±?0.17?μg/cm2/h. The TEM image of optimized formulation exhibited sealed and spherical shape vesicles. Results of thermoanalytical techniques demonstrated that the prepared transethosomes vesicles formulation had fluidized the rigid membrane of rat’s skin for smoother penetration of fisetin transethosomes. The confocal study results presented well distribution and penetration of Rhodamine B loaded transethosomes vesicles formulation up to deeper layers of the rat’s skin as compared to the Rhodamine B-hydro alcoholic solution. Present study data revealed that the developed transethosomes vesicles formulation was found to be a potentially useful drug carrier for fisetin dermal delivery.
机译:进行本研究是为了优化用于真皮非瑟汀递送的穿脂质体制剂。使用“ Box–Behnken设计”进行配方的优化。自变量为类脂脂质S 100,乙醇和胆酸钠。对制备的制剂进行囊泡大小,包封率和体外皮肤渗透研究进行表征。通过优化配方进行囊泡-皮肤相互作用,共聚焦激光扫描显微镜和皮肤动力学研究。本研究结果表明,优化后的制剂的囊泡大小为74.21?±?2.65?nm,ζ电势为?11.0?mV,包封效率为68.31?±?1.48%,通量为4.13?±?0.17?g / g平方厘米/小时优化配方的TEM图像显示密封和球形囊泡。热分析技术的结果表明,所制备的经核小体囊泡制剂已使大鼠皮肤的刚性膜流化,从而使非瑟定经皮小体的渗透更平稳。共聚焦研究结果表明,与若丹明B-氢乙醇溶液相比,若丹明B负载的透膜小体制剂在大鼠皮肤深层的分布和渗透性良好。目前的研究数据表明,已开发出的跨脂质体囊泡制剂是用于非瑟汀皮肤递送的潜在有用的药物载体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号